Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Measurement of Trough Levels of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT01078311 is registered in ClinicalTrials.gov with South West Sydney Local Health District as lead sponsor.

NCT NCT01078311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01078311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Measurement of Trough Levels of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
South West Sydney Local Health District
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2010
Completion date
February 28, 2014
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer